X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1038) 1038
Publication (121) 121
Conference Proceeding (8) 8
Book / eBook (3) 3
Book Review (3) 3
Book Chapter (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (578) 578
humans (519) 519
index medicus (365) 365
female (340) 340
male (300) 300
adult (293) 293
middle aged (291) 291
aged (259) 259
cancer (213) 213
sarcoma (186) 186
chemotherapy (177) 177
treatment outcome (146) 146
prognosis (144) 144
aged, 80 and over (129) 129
tumors (114) 114
adolescent (106) 106
imatinib mesylate (102) 102
disease-free survival (99) 99
life sciences (94) 94
antineoplastic agents - therapeutic use (93) 93
sarcoma - drug therapy (91) 91
survival (90) 90
young adult (86) 86
retrospective studies (80) 80
gastrointestinal stromal tumors (79) 79
imatinib (79) 79
hematology, oncology and palliative medicine (72) 72
antineoplastic combined chemotherapy protocols - therapeutic use (69) 69
france (68) 68
metastasis (67) 67
therapy (67) 67
gastrointestinal stromal tumors - drug therapy (66) 66
trial (66) 66
surgery (65) 65
sarcoma - pathology (64) 64
care and treatment (63) 63
survival analysis (62) 62
analysis (58) 58
doxorubicin (57) 57
gist (56) 56
research (56) 56
diagnosis (55) 55
phase-ii (55) 55
benzamides (54) 54
expression (54) 54
neoplasm staging (54) 54
soft-tissue sarcoma (54) 54
patients (53) 53
[ sdv.can ] life sciences [q-bio]/cancer (52) 52
combined modality therapy (52) 52
follow-up studies (52) 52
pyrimidines - therapeutic use (51) 51
survival rate (51) 51
antineoplastic agents - adverse effects (50) 50
prognostic-factors (49) 49
clinical trials (48) 48
management (48) 48
efficacy (47) 47
soft-tissue sarcomas (46) 46
disease progression (44) 44
piperazines - therapeutic use (44) 44
c-kit (43) 43
child (43) 43
gastrointestinal stromal tumors - pathology (43) 43
hematology (43) 43
ifosfamide (43) 43
neoplasm metastasis (43) 43
soft tissue sarcoma (42) 42
kaplan-meier estimate (41) 41
mutations (41) 41
sarcoma - mortality (41) 41
kit (38) 38
mesylate (38) 38
mutation (38) 38
prospective studies (38) 38
risk factors (38) 38
multivariate analysis (37) 37
radiotherapy (37) 37
solid tumors (37) 37
drug administration schedule (36) 36
sarcoma - therapy (35) 35
soft tissue neoplasms - drug therapy (35) 35
tyrosine kinase inhibitor (35) 35
cancer therapies (34) 34
time factors (34) 34
trabectedin (34) 34
antineoplastic agents (33) 33
antineoplastic agents - administration & dosage (33) 33
breast cancer (33) 33
medicine & public health (33) 33
research article (33) 33
sunitinib (33) 33
drug therapy (32) 32
mesh : humans (32) 32
phase-ii trial (32) 32
cancer research (30) 30
gastrointestinal stromal tumors - genetics (30) 30
pathology (30) 30
dose-response relationship, drug (29) 29
soft tissue neoplasms - pathology (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FUTURE ONCOLOGY, ISSN 1479-6694, 05/2018, Volume 14, Issue 10, pp. 1 - 2
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 01/2017, Volume 13, Issue 1, pp. 1 - 2
Journal Article
CURRENT OPINION IN ONCOLOGY, ISSN 1040-8746, 07/2019, Volume 31, Issue 4, pp. 302 - 303
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix21 - ix21
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2010, Volume 37, Issue 5, pp. 373 - 384
Summary The introduction of molecularly targeted therapies has ushered in a considerable transformation in the management of gastrointestinal stromal tumors... 
Hematology, Oncology and Palliative Medicine | Imatinib | Sunitinib | GIST | Tyrosine kinase inhibitor | Gastrointestinal stromal tumor | PDGFRA MUTATIONS | BCR-ABL | RESIDUAL DISEASE | OF-FUNCTION MUTATIONS | PHASE-II TRIAL | SELECTIVE INHIBITOR | ONCOLOGY | KIT MUTATIONS | DOSE IMATINIB | GASTROINTESTINAL STROMAL TUMORS | IMATINIB MESYLATE | Piperazines - administration & dosage | Protein-Tyrosine Kinases - therapeutic use | Prognosis | Humans | Male | Indoles - administration & dosage | Drug Delivery Systems | Enzyme Inhibitors - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Pyrroles - administration & dosage | Pyrroles - adverse effects | Adult | Female | Gastrointestinal Stromal Tumors - mortality | Angiogenesis Inhibitors - adverse effects | Gastrointestinal Stromal Tumors - genetics | Enzyme Inhibitors - adverse effects | Gastrointestinal Stromal Tumors - surgery | Pyrimidines - administration & dosage | Imatinib Mesylate | Piperazines - adverse effects | Disease-Free Survival | Pilot Projects | Indoles - adverse effects | Gastrointestinal Stromal Tumors - drug therapy | Pyrimidines - adverse effects | Survival Analysis | Benzamides | Neoplasm Staging | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Phenols | Care and treatment | Tumors | Enzyme Inhibitors | Piperazines | Pyrroles | Angiogenesis Inhibitors | Life Sciences | Pyrimidines | Indoles | Protein-Tyrosine Kinases | Gastrointestinal Stromal Tumors | Cancer
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 07/2018, Volume 30, Issue 4, pp. 240 - 242
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue suppl_4, pp. iv31 - iv31
Abstract The biology of soft tissue sarcomas and locally aggressive connective tissue tumors evolves rapidly. At least seven molecular subgroups of connective... 
Journal Article
EXPERT REVIEW OF ANTICANCER THERAPY, ISSN 1473-7140, 06/2013, Volume 13, Issue 6, pp. 1 - 2
Journal Article
Future Oncology, ISSN 1479-6694, 05/2018, Volume 14, Issue 10s, pp. 3 - 13
Surgery (+ radiation therapy in selected cases) is standard treatment for adult-type localized soft tissue sarcoma (STS). Accumulating randomized clinical... 
management | trabectedin | advanced soft tissue sarcoma | MULTICENTER | DOSE ADJUVANT CHEMOTHERAPY | RANDOMIZED CLINICAL-TRIAL | DOXORUBICIN | PHASE-II | OPEN-LABEL | IFOSFAMIDE | METASTATIC LIPOSARCOMA | ONCOLOGY | LEIOMYOSARCOMA
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 726 - 736
Journal Article
BULLETIN DU CANCER, ISSN 0007-4551, 04/2014, Volume 101, Issue 4, pp. 340 - 340
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2010, Volume 16, Issue Supplement 7, pp. CN1-2 - CN1-2
Journal Article
Seminars in Oncology, ISSN 0093-7754, 04/2011, Volume 38, Issue 1, pp. S3 - S9
The development of tyrosine kinase inhibitors (TKIs) for the treatment of chronic myelogenous leukemia (CML) was based on the discovery that CML stem and... 
MESYLATE | PDGFRA | IMATINIB-RESISTANT | TRANSPORT | ONCOLOGY | GIANT-CELL TUMOR | BCR-ABL | MUTATION | C-KIT | AMN107 | IN-VITRO ACTIVITY | Clinical Trials as Topic | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Humans | Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1879 - 1886
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.